Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.
Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE; American Society of Clinical Oncology; American Society of Hematology. Rizzo JD, et al. Among authors: regan dh. J Clin Oncol. 2008 Jan 1;26(1):132-49. doi: 10.1200/JCO.2007.14.3396. Epub 2007 Oct 22. J Clin Oncol. 2008. PMID: 17954713
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS; American Society of Clinical Oncology; Americcan Society of Hematology. Rizzo JD, et al. Among authors: regan dh. Blood. 2002 Oct 1;100(7):2303-20. doi: 10.1182/blood-2002-06-1767. Blood. 2002. PMID: 12239138 Free article.
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS; American Society of Clinical Oncology. American Society of Hematology. Rizzo JD, et al. Among authors: regan dh. J Clin Oncol. 2002 Oct 1;20(19):4083-107. doi: 10.1200/JCO.2002.07.177. J Clin Oncol. 2002. PMID: 12351606
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.
Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE. Rizzo JD, et al. Among authors: regan dh. Blood. 2008 Jan 1;111(1):25-41. doi: 10.1182/blood-2007-08-109488. Epub 2007 Oct 22. Blood. 2008. PMID: 17954703 Free article. Review.
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR; American Society of Hematology and the American Society of Clinical Oncology Practice Guideline Update Committee. Rizzo JD, et al. Among authors: regan dh. Blood. 2010 Nov 18;116(20):4045-59. doi: 10.1182/blood-2010-08-300541. Epub 2010 Oct 25. Blood. 2010. PMID: 20974674 Free article. Review.
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR; American Society of Clinical Oncology; American Society of Hematology. Rizzo JD, et al. Among authors: regan dh. J Clin Oncol. 2010 Nov 20;28(33):4996-5010. doi: 10.1200/JCO.2010.29.2201. Epub 2010 Oct 25. J Clin Oncol. 2010. PMID: 20975064 Review.
Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin, and cyclophosphamide in stage II and III breast cancer.
Jones SE, Khandelwal P, McIntyre K, Mennel R, Orr D, Kirby R, Agura E, Duncan L, Hyman W, Roque T, Regan D, Schuster M, Dimitrov N, Garrison L, Lange M. Jones SE, et al. J Clin Oncol. 1999 Oct;17(10):3025-32. doi: 10.1200/JCO.1999.17.10.3025. J Clin Oncol. 1999. PMID: 10506596 Clinical Trial.
Evaluation: continued need for randomized trials.
Beveridge RA, Regan DH. Beveridge RA, et al. Among authors: regan dh. J Clin Oncol. 2000 Sep 15;18(18):3321-2. doi: 10.1200/JCO.2000.18.18.3321. J Clin Oncol. 2000. PMID: 10986068 No abstract available.
Multidimensional approach to invasive species prevention.
Briski E, Allinger LE, Balcer M, Cangelosi A, Fanberg L, Markee TP, Mays N, Polkinghorne CN, Prihoda KR, Reavie ED, Regan DH, Reid DM, Saillard HJ, Schwerdt T, Schaefer H, TenEyck M, Wiley CJ, Bailey SA. Briski E, et al. Among authors: regan dh. Environ Sci Technol. 2013 Feb 5;47(3):1216-21. doi: 10.1021/es3029445. Environ Sci Technol. 2013. PMID: 23293915 Free article.
19 results